Toward a Neuro-Cognitive Animal Model of the Cognitive Symptoms of Schizophrenia: Disruption of Cortical Cholinergic Neurotransmission Following Repeated Amphetamine Exposure in Attentional Task-Performing, but Not Non-Performing, Rats
- 14 February 2007
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 32 (10) , 2074-2086
- https://doi.org/10.1038/sj.npp.1301352
Abstract
Impairments in attentional functions and capacities represent core aspects of the cognitive symptoms of schizophrenia. Attentional performance has been demonstrated to depend on the integrity and activity of cortical cholinergic inputs. The neurobiological, behavioral, and cognitive effects of repeated exposure to psychostimulants model important aspects of schizophrenia. In the present experiment, prefrontal acetylcholine (ACh) release was measured in attentional task-performing and non-performing rats pretreated with an escalating dosing regimen of amphetamine (AMPH) and following challenges with AMPH. In non-performing rats, pretreatment with AMPH did not affect the increases in ACh release produced by AMPH-challenges. In contrast, attentional task performance-associated increases in ACh release were attenuated in AMPH-pretreated and AMPH-challenged rats. This effect of repeated AMPH exposure on ACh release was already present before task-onset, suggesting that the loss of cognitive control that characterized these animals' performance was a result of cholinergic dysregulation. The findings indicate that the demonstration of repeated AMPH-induced dysregulation of the prefrontal cholinergic input system depends on interactions between the effects of repeated AMPH exposure and cognitive performance-associated recruitment of this neuronal system. Repeated AMPH-induced disruption of prefrontal cholinergic activity and attentional performance represents a useful model to investigate the cholinergic mechanisms contributing to the cognitive impairments of schizophrenia.Keywords
This publication has 92 references indexed in Scilit:
- Abnormal Neurotransmitter Release Underlying Behavioral and Cognitive Disorders: Toward Concepts of Dynamic and Function-Specific DysregulationNeuropsychopharmacology, 2006
- Baseline Neurocognitive Deficits in the CATIE Schizophrenia TrialNeuropsychopharmacology, 2006
- Repeated Amphetamine Administration Decreases D1Dopamine Receptor-Mediated Inhibition of Voltage-Gated Sodium Currents in the Prefrontal CortexJournal of Neuroscience, 2006
- Structural plasticity associated with exposure to drugs of abusePublished by Elsevier ,2004
- Visceral Afferent Bias on Cortical Processing: Role of Adrenergic Afferents to the Basal Forebrain Cholinergic System.Behavioral Neuroscience, 2004
- Cholinergic systems and schizophrenia: primary pathology or epiphenomena?Journal of Chemical Neuroanatomy, 2001
- Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug TreatmentAmerican Journal of Psychiatry, 2001
- In Vivo Neurochemical Correlates of Cognitive Processes: Methodological and Conceptual ChallengesReviews in the Neurosciences, 1999
- A Case of Recurrent Psychosis Associated with Amphetamine AddictionJournal of Mental Science, 1950
- Acute Psychosis Caused by Dextro-amphetamineBMJ, 1949